本研究针对高危经皮冠状动脉介入治疗（HR-PCI）中机械循环支持（MCS）设备的选择难题，通过分析美国电子健康记录（EHR）数据，比较Impella与主动脉内球囊反搏（IABP）对非急诊患者的临床结局及左心室射血分数（LVEF）恢复的影响。结果显示，Impella支持的患者30 ...
本研究通过分析34个国际中心的927例心源性休克（CS）患者数据，首次系统评估了Impella 5.5超FDA批准14天使用期限的临床效果 ...
DANVERS, Mass.--(BUSINESS WIRE)--Abiomed’s (NASDAQ: ABMD) newest heart pump, the Impella 5.5 with SmartAssist, has received U.S. Food and Drug Administration (FDA) pre-market approval (PMA) for safety ...
DANVERS, Mass.--(BUSINESS WIRE)--To mark the five year anniversary of the study by Stretch, et al., on cost and outcomes trends for short-term mechanical circulatory support, Abiomed announces a ...
On Mar 12, we issued an updated research report on ABIOMED, Inc.ABMD, a leading medical product developer. The stock carries a Zacks Rank #3 (Hold). The company's robust demand for the Impella product ...
The Impella heart pump is a small pump that a healthcare professional can insert without surgery. It can help maintain blood flow in people who have CAD, are recovering from cardiogenic shock, or are ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈